Breast milk is widely recognized as the optimal nutrition for infants, providing essential nutrients, immune factors, and developmental signals that formula cannot fully replicate. However, PFAS — like many lipophilic and protein-binding environmental chemicals — accumulate in breast milk and are transferred to nursing infants, creating a complex situation for mothers in PFAS-contaminated areas.
How PFAS Enter Breast Milk
PFAS in the mother’s blood cross into mammary gland tissue and are secreted into breast milk. The concentration of PFAS in breast milk reflects the mother’s total body burden — her lifetime accumulation of PFAS from water, food, and other sources. PFAS concentrations in breast milk are typically lower than in maternal serum, but the large volume of breast milk consumed by nursing infants — up to 800 mL per day — means that total infant PFAS intake from breastfeeding can be substantial.
Research has documented PFAS in breast milk samples collected from women worldwide, including in remote Arctic communities with limited industrial exposure, demonstrating the global distribution of these compounds. Concentrations are highest in women from areas with PFAS-contaminated water supplies or occupational exposures.
Infant PFAS Exposure from Breastfeeding
Studies have found that breastfed infants have higher serum PFAS levels than formula-fed infants when the mother has elevated PFAS body burden. This suggests that breastfeeding is a meaningful PFAS exposure pathway in contaminated areas. Short-chain PFAS compounds appear in breast milk at higher relative concentrations than long-chain compounds, reflecting differences in protein binding and mammary gland secretion.
After weaning, infant PFAS levels gradually decline as the breastfeeding exposure source is removed and the infant’s own elimination mechanisms operate. However, the PFAS received during infancy contribute to the child’s total body burden and may have health implications given the particular vulnerability of the developing infant.
Balancing Breastfeeding Benefits and PFAS Risks
Public health organizations including the American Academy of Pediatrics and the World Health Organization continue to recommend breastfeeding even in areas with PFAS contamination, recognizing that the documented benefits of breastfeeding for infant health, neurodevelopment, and immune function generally outweigh the risks from PFAS transfer. The immune factors, prebiotics, and nutritional composition of breast milk are not easily replicated by formula.
However, the recommendation is not unconditional. In situations of very high maternal PFAS body burden — such as in communities with severe historical contamination — individual risk-benefit discussions with healthcare providers are warranted. Women in these situations should be supported in making informed decisions based on measured maternal PFAS levels rather than general population assumptions.
Reducing PFAS Transfer Through Pre-Pregnancy Exposure Reduction
The most effective strategy for reducing infant PFAS exposure through breast milk is reducing maternal PFAS exposure before and during pregnancy. Since PFAS body burden declines slowly due to long half-lives, initiating water filtration years before planned pregnancy provides the longest window for body burden reduction before breastfeeding begins.
For currently nursing mothers, switching to PFAS-filtered water reduces ongoing maternal PFAS intake and prevents further accumulation, supporting gradual body burden decline even during the breastfeeding period. Testing household water for PFAS is an important first step for nursing mothers in areas of potential contamination.